RxDoctor Payments Data

Gary Winfrey, DO

Family Medicine · Clermont, FLNPI 1396034526

Payments from drug & device makers

$1,419in general payments, 2019–2025

Across 75 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$224
  • Novo Nordisk$173
  • AstraZeneca$137
  • Amgen$116
  • Exact Sciences$101
  • GSK$75
  • plus $594 from 20 others

What the payments were for

  • Food & beverage$1,419100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,419 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$180,839
Medicare patients
432
Services billed
1,902

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide144$214,680
OzempicSemaglutide85$97,272
EliquisApixaban89$86,397
JardianceEmpagliflozin30$40,588
Repatha SyringeEvolocumab42$33,043
XareltoRivaroxaban20$28,384
TrulicityDulaglutide28$26,707
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$19,931
LinzessLinaclotide15$14,798
MyrbetriqMirabegron13$12,682
VascepaIcosapent Ethyl22$11,032
Levothyroxine Sodium421$4,582
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$4,458
SynthroidLevothyroxine Sodium77$4,301
Rosuvastatin Calcium412$3,960

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$224$241,386172 claims
Novo NordiskOzempic$173$97,27285 claims
PfizerEliquis, Paxlovid$56$87,744108 claims
Boehringer IngelheimJardiance$21$40,58830 claims
GSKTrelegy Ellipta, Arnuity Ellipta$75$23,10141 claims
AbbVieLinzess, Synthroid$41$19,09992 claims
Astellas Pharma US IncMyrbetriq$39$12,68213 claims
Eisai Inc.Dayvigo$26$3,66411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Clermont

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →